RAPT Therapeutics
RAPT
RAPT was delisted on the 2nd of March, 2026.
84 hedge funds and large institutions have $527M invested in RAPT Therapeutics in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 31 increasing their positions, 26 reducing their positions, and 10 closing their positions.
151% more call options, than puts
Call options by funds: $11.5M | Put options by funds: $4.57M
19% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 26
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
0.69% more ownership
Funds ownership: 11.85% → 12.53% (+0.69%)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
1% less funds holding
Funds holding: 85 → 84 (-1)
15% less capital invested
Capital invested by funds: $616M → $527M (-$89.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Column Group
San Francisco,
California
|
+$21.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.2M |
| 3 |
O
OrbiMed
New York
|
+$8.41M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$8.34M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$14.8M |
| 2 |
State Street
Boston,
Massachusetts
|
-$14.3M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.08M |
| 4 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$2.42M |
| 5 |
Rafferty Asset Management
New York
|
-$1.84M |
RAPT Hedge Fund Activity: Q2 2022 in Review
84 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in RAPT Therapeutics (RAPT) for Q2 2022, worth a combined $527M — down 15% from $616M a quarter earlier.
Fund positioning in RAPT was balanced in Q2 2022: 10 funds opened new positions, 10 closed out, 31 added to existing stakes and 26 trimmed.
The largest buyer was Column Group, adding an estimated $21.3M. The largest seller was Perceptive Advisors, cutting an estimated $14.8M.
- 84 institutional investors held RAPT Therapeutics (RAPT) as of Q2 2022, down from 85 in Q1 2022.
- Funds reported $527M of RAPT Therapeutics stock for Q2 2022, down 15% quarter-over-quarter.
- 10 funds opened new RAPT Therapeutics positions in Q2 2022 and 10 closed out, a net change of 0 holders.
- The largest RAPT Therapeutics buyer in Q2 2022 was Column Group, an estimated $21.3M added.
- The largest RAPT Therapeutics seller in Q2 2022 was Perceptive Advisors, an estimated $14.8M sold.
Based on aggregated 13F filings for Q2 2022.